Alfadil Haroon: New Genetic Insights into Bone Marrow Failure Syndromes
Alfadil Haroon, Assistant Consultant of Hematology at King Faisal Specialist Hospital and Research Centre, Assistant Professor at Alfaisal University, shared a post on LinkedIn:
“Happy to share our book chapter titled ‘Newly Recognized Marrow Failure Syndromes‘ in the textbook on bone marrow failure syndromes.
This chapter reviews recently identified bone marrow failure syndromes described between 2012 and 2025, expanding beyond the classical conditions such as Fanconi anemia and Dyskeratosis congenita.
Advances in Next-Generation Sequencing have enabled the discovery of several novel genetic etiologies, including MYSM1, DNAJC21, ADH5/ALDH2, MECOM, ERCC6L2,TP53,OSM, and SAMD9/SAMD9L.
These findings are reshaping our understanding of inherited BMF, highlighting diverse clinical phenotypes, early onset cytopenias, and variable risks of progression to myeloid malignancies.
Improved genomic insights are helping clinicians refine diagnosis, risk assessment, and treatment strategies.”
Stay updated with Hemostasis Today.
-
Mar 7, 2026, 14:48Shaine Morris: Save the Date for the Texas Children’s Hospital Second Pediatric Aortopathy Symposium
-
Mar 7, 2026, 14:46Ahmad Hazri Mohamed Aris: Strengthening Bleeding Disorders Care Through WFH PACT 2026–2030
-
Mar 7, 2026, 14:42Megan Adediran: When Should Heavy Bleeding Stop Being Called Normal?
-
Mar 7, 2026, 14:41Heghine Khachatryan: Best-Practice Recommendations for Implementing Shared Decision-Making in Hemophilia Care
-
Mar 7, 2026, 14:37Julie Kennedy Lesch: Driving Progress for People Living with Sickle Cell Disease
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Adrian Gottschlich: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders